481 related articles for article (PubMed ID: 20055166)
1. [Research progress of neuraminidase inhibitors for anti-influenza].
Liu AL; Wang HD; Yang F; Du GH
Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
[TBL] [Abstract][Full Text] [Related]
2. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
Mohr PG; Geyer H; McKimm-Breschkin JL
Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
[TBL] [Abstract][Full Text] [Related]
3. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
4. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
5. Resistance to neuraminidase inhibitors.
Dolin R
Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
[No Abstract] [Full Text] [Related]
6. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
7. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitor resistance in influenza viruses.
Reece PA
J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus resistance to neuraminidase inhibitors.
Samson M; Pizzorno A; Abed Y; Boivin G
Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
[TBL] [Abstract][Full Text] [Related]
10. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A; Brydak LB; Wardyn AK
Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
[TBL] [Abstract][Full Text] [Related]
11. [Present and future in development of new anti-influenza drugs].
Watanabe A
Nihon Rinsho; 2010 Sep; 68(9):1685-9. PubMed ID: 20845748
[TBL] [Abstract][Full Text] [Related]
12. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
13. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
14. Drugs: Lines of defence.
Palmer R
Nature; 2011 Dec; 480(7376):S9-10. PubMed ID: 22158299
[No Abstract] [Full Text] [Related]
15. The war against influenza: discovery and development of sialidase inhibitors.
von Itzstein M
Nat Rev Drug Discov; 2007 Dec; 6(12):967-74. PubMed ID: 18049471
[TBL] [Abstract][Full Text] [Related]
16. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
Farrukee R; Mosse J; Hurt AC
Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drugs for influenza.
Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
[No Abstract] [Full Text] [Related]
18. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
20. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]